Czechia, June 27 -- Czechia based AbbVie s.r.o. has secured contract from Fakultni nemocnice Hradec Kralove for Immunosuppressive agents - medicinal products containing risankizumab, tofacitinib, Aprremilast, mirikizumab, deukravacitinib, voclosporin, siltuximab. The value of the contract is worth 4488771512 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....